Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Financial Results

Every financial results filing by a US-listed company that our alert engine sent, newest first.

7:06 AM ET 8-K
Financial Results Bristol Myers Squibb Co BMY

Bristol Myers Squibb Financial Results

Bristol Myers Squibb reported third quarter 2026 revenues of $13.1 billion, a 7% increase driven by double-digit growth in its Growth Portfolio. The company raised its full-year 2026 revenue guidance to a range of $49.75 billion to $50.25 billion following strong performance from key products like Opdivo Qvantig and Reblozyl.

Term
Q3 2026

“We delivered another quarter of double-digit growth in our Growth Portfolio, which increased 12% and reflects the continued momentum across our diversified portfolio. The approval of Zenbexus, the first-in-class CELMoD, brings a new class of treatment to market for patients with multiple myeloma and is one of several recent pipeline milestones. As we look forward to additional late-stage data in the near term, we remain focused on executing with discipline, investing where we see the greatest opportunity and strengthening the foundation for sustainable growth.”

Christopher Boerner, Ph.D., board chair and chief executive officer, Bristol Myers Squibb
7:06 AM ET 8-K
Financial Results Price T Rowe Group Inc TROW

Price T Rowe Group Financial Results

T. Rowe Price Group reported third quarter 2026 net revenues of $2.0 billion and diluted EPS of $2.79. Assets under management (AUM) ended the period at $1.86 trillion, despite net client outflows of $28.3 billion during the quarter.

“We continue to expand our ETF, SMA, and model portfolio businesses, extending our active investment expertise to more clients through a broader range of portfolio solutions. With innovative product launches, improving investment performance, and continued progress on our strategic partnerships, we are well positioned to continue delivering long-term value for clients and stockholders.”

Rob Sharps, chair and CEO
7:06 AM ET 8-K
Financial Results Bicycle Therapeutics PLC BCYC

Bicycle Therapeutics Financial Results

Bicycle Therapeutics reported third quarter 2026 financial results, highlighting a cash position of $469.9 million and a runway extending into 2030. The company also announced that the FDA granted Orphan Drug Designation to nuzefatide pevedotin for pancreatic cancer and plans to initiate its first company-sponsored radioligand clinical trial in 2H 2027.

“We are pleased with the continued progress made across our pipeline during the third quarter, as we advance nuzefatide pevedotin in the Phase 2 clinical trial in patients with recurrent pancreatic ductal adenocarcinoma and build our emerging pipeline of next-generation radioligands.”

Kevin Lee, Ph.D., Bicycle CEO

“We remain focused on disciplined execution across our prioritized programs and believe our growing clinical data continue to demonstrate the potential of Bicycle® molecules to deliver highly targeted therapies with differentiated benefit/risk profiles.”

Kevin Lee, Ph.D., Bicycle CEO
7:06 AM ET 8-K
Financial Results Life Time Group Holdings, Inc. LTH

Life Time Group Holdings Financial Results

Life Time Group Holdings reported third quarter 2026 financial results with total revenue increasing 14.2% to $893.5 million and net income rising 4.0% to $106.5 million. The company raised its full-year 2026 outlook and remains on track to open 14 new clubs this year with a robust pipeline for 2027.

Term
Q3 2026

“Our third quarter results reflect our continued delivery of exceptional member experiences and the strength of our brand. Member engagement continues to rise and our in-center businesses are performing very well, resulting in higher revenue per membership. We are on track to open all 14 new clubs planned for this year, and nearly all of our clubs planned for 2027 are already under construction. With our low leverage, strong cash flow and robust real estate pipeline, we are well positioned for long-term growth.”

Bahram Akradi, Founder, Chairman and CEO
7:06 AM ET 8-K
Financial Results Howmet Aerospace Inc. HWM

Howmet Aerospace Financial Results

Howmet Aerospace reported record Q3 2026 revenue growth of 29% year-over-year to $2.7 billion, driven by robust commercial aerospace demand. The company's Board authorized a significant $5 billion increase to its share repurchase program and raised full-year 2026 guidance.

Term
Q3 2026

“Howmet's performance was solid in all dimensions, with third quarter results exceeding the high end of guidance. Revenue grew 29% year over year and 25% organically, the strongest quarterly growth rate on record for Howmet.”

John Plant, Executive Chairman and Chief Executive Officer

“Our trajectory points to a healthy fourth quarter and the conclusion of another strong year for Howmet. The commercial aerospace market continues to look robust, underpinned by the extraordinary aircraft order backlog that supports expected production volume increases throughout 2027 and beyond.”

John Plant, Executive Chairman and Chief Executive Officer
7:06 AM ET 10-Q
Financial Results Phathom Pharmaceuticals, Inc. PHAT

Phathom Pharmaceuticals Q3 2026 Results: Net Loss of $13.9M, Loss Narrows

Phathom Pharmaceuticals reported a significant increase in net product revenue to $84.7 million for Q3 2026, up from $49.5 million in the prior year. The company substantially narrowed its quarterly net loss to $13.9 million compared to $30.0 million in Q3 2025, driven by higher gross profits and reduced operating expenses.

Key figure
Net loss $13.9M
7:05 AM ET 8-K
Financial Results Myers Industries Inc MYE

Myers Industries Financial Results

Myers Industries reported Q3 2026 revenue growth of 8.1% to $171.3 million, driven by strong performance in the Infrastructure and Food & Beverage end markets. However, margins were pressured by a significant spike in resin costs and unfavorable product mix, leading to a decrease in operating income. The company completed the divestiture of Myers Tire Supply during the period to focus on its core specialty engineered products growth platforms.

Term
Q3 2026

“Our Focused Transformation initiatives continued to drive commercial excellence across our growth platforms, resulting in a year-over-year increase in revenue. At the same time, a significant spike in resin cost and unfavorable product mix pressured gross margins in the quarter. Resin costs have since declined and stabilized from their recent peak, while our pricing actions remain in place and continue to support margin recovery.”

Aaron Schapper, President and CEO
7:05 AM ET 8-K
Financial Results Phathom Pharmaceuticals, Inc. PHAT

Phathom Pharmaceuticals Financial Results

Phathom Pharmaceuticals reported Q3 2026 net revenues of $84.7 million, a 71% increase year-over-year, driven by the commercial momentum of VOQUEZNA which surpassed 2 million total prescriptions filled. The company achieved positive operating cash flow for the second consecutive quarter and initiated a Phase 3 study for as-needed use of VOQUEZNA in NERD patients.

Term
Q3 2026

“We are pleased to report continued solid revenue growth and improved operating profitability for the third quarter. We continue to grow VOQUEZNA prescribing depth among GI providers and have implemented several initiatives designed to make it easier for physicians to prescribe and patients to obtain our first-in-class GERD treatment. These efforts build on our commercial momentum, which includes recently reaching the milestone of two million VOQUEZNA prescriptions filled.”

Steve Basta, President and Chief Executive Officer of Phathom

“Our third quarter results reflect Phathom’s significant financial transformation, with revenue growth of 71% year over year and positive cash flow from operations for the second consecutive quarter. We have established a stronger financial foundation through continued revenue growth and disciplined expense management, while maintaining the flexibility to invest in our commercial and clinical development priorities. We remain confident in our ability to meet our financial obligations and deliver on our full-year 2026 guidance.”

Sanjeev Narula, Chief Financial and Business Officer of Phathom
7:05 AM ET 8-K
Financial Results Hilton Grand Vacations Inc. HGV

Hilton Grand Vacations Financial Results

Hilton Grand Vacations reported Q3 2026 total revenues of $1.961 billion and net income of $291 million, significantly impacted by $536 million in net construction recognition. The company lowered its full-year 2026 Adjusted EBITDA guidance due to sales execution initiatives taking longer to ramp than anticipated.

Term
Q3 2026

“The underlying business model, recurring revenue streams, and cash flow generation of our business remained resilient in the third quarter, but our sales results fell short of our expectations as the initiatives we put in place over the summer to improve execution are taking longer to ramp than we anticipated.”

Mark Wang, CEO of Hilton Grand Vacations

“Looking ahead, we are updating our outlook to reflect our year-to-date performance and a more realistic view on the timing and ramp of our initiatives.”

Mark Wang, CEO of Hilton Grand Vacations
7:04 AM ET 8-K
Financial Results Incyte Corp INCY

Incyte Financial Results

Incyte reported third quarter 2026 total revenue of $1.56 billion, a 14% year-over-year increase driven by strong sales of Jakafi ($827M) and Opzelura ($255M). The company raised its full-year 2026 financial guidance for total net sales and key product portfolios. Results were impacted by a one-time $1.23 billion R&D expense related to the acquisition of Vega Therapeutics.

Term
Q3 2026

“Our third quarter was marked by strong commercial performance, meaningful pipeline progress and important regulatory achievements. Net sales growth was strong in both the U.S. and internationally, creating a durable core business beyond Jakafi.”

Bill Meury, Chief Executive Officer, Incyte
7:04 AM ET 8-K
Financial Results ELI Lilly & Co LLY

ELI Lilly & Financial Results

Eli Lilly reported Q3 2026 revenue of $24.4 billion, a 39% increase driven by strong demand for Mounjaro and Zepbound. The company raised its full-year 2026 revenue guidance midpoint by $5.5 billion to a range of $91.0 to $92.0 billion, reflecting robust global consumer demand and expanded coverage for obesity care.

Term
Q3 2026

“Lilly had another strong quarter, exceeding our prior expectations and allowing us to raise our full-year outlook. Revenue growth was driven by broad global consumer demand for Mounjaro and Zepbound, the global launches of Foundayo, expanded U.S. coverage for obesity care and a doubling in our newest products in oncology, immunology and neuroscience.”

David A. Ricks, Lilly chair and CEO
7:03 AM ET 8-K
Financial Results Pagaya Technologies Ltd. PGY

Pagaya Technologies Financial Results

Pagaya Technologies reported record third-quarter 2026 results with GAAP net income of $50 million and total revenue of $390 million, up 12% year-over-year. The company achieved record network volume of $3.6 billion and raised its full-year 2026 GAAP net income guidance to a range of $162 million to $182 million.

Term
Q3 2026

“Our momentum is building on itself: more partners, more products, and more applications feeding a network that is becoming essential infrastructure for consumer lending.”

Gal Krubiner, CEO and Co-Founder
7:03 AM ET 10-Q
Financial Results PBF Energy Inc. PBF

PBF Energy Q3 2026 Results: Net Income $1.53B, Up 799.1% YoY

PBF Energy Inc. reported its third quarter 2026 results, noting that it operates as a holding company with a 99.3% interest in PBF LLC. The report highlights significant operational risks including recent fires at the Martinez and Chalmette refineries, volatility in RINs pricing, and ongoing geopolitical conflicts affecting global energy markets.

Key figure
Net income $1.53B · +799.1% YoY
7:03 AM ET 10-Q
Financial Results Tradeweb Markets Inc. TW ▶ Call

Tradeweb Markets Q3 2026 Results: Net Income $197M, Up 6.4% YoY

Tradeweb Markets Inc. reported its financial results for the third quarter of 2026, continuing its structure as a holding company for Tradeweb Markets LLC. The filing details the company's multi-class stock structure and provides reconciliations for non-GAAP measures such as Adjusted EBITDA and Free Cash Flow to evaluate operational performance.

Key figure
Net income $197M · +6.4% YoY
7:03 AM ET 8-K
Financial Results Altisource Portfolio Solutions S.A. ASPS

Altisource Portfolio Solutions Financial Results

Altisource Portfolio Solutions reported third quarter 2026 financial results, highlighted by a 26% year-over-year increase in service revenue to $49.8 million. The company narrowed its net loss to $1.4 million and achieved Adjusted EBITDA of $4.3 million as it continues to ramp up new customer wins and implement AI-driven efficiency initiatives. Management reaffirmed its 'Project 45' objective, targeting a $45 million run-rate Adjusted EBITDA by the fourth quarter of 2028.

Term
Q3 2026

“We are pleased with our third quarter 2026 performance, with year-over-year Service revenue and Adjusted EBITDA growth in both segments. Customer wins continued to ramp, driving a 26% increase in total Company Service revenue, while revenue from customers outside of Onity and Rithm grew 96% year over year and now represents 72% of our Service revenue. Additionally, our AI and other efficiency initiatives began accelerating product development speed and are anticipated to drive scalability and operating leverage over the upcoming quarters.”

William B. Shepro, Chairman and Chief Executive Officer

“Together, the continued ramp and seasoning of customer wins, greater operating leverage and disciplined cost management represent the core building blocks of Project 45—our objective of reaching $45 million of run-rate Adjusted EBITDA by the fourth quarter of 2028.”

William B. Shepro, Chairman and Chief Executive Officer
7:02 AM ET 8-K
Financial Results Crocs, Inc. CROX

Crocs Financial Results

Crocs, Inc. reported record third quarter 2026 results with consolidated revenues of $1.04B, driven by 4.4% growth in the Crocs Brand and a return to growth for HEYDUDE. The company raised its full-year 2026 revenue growth outlook to approximately 3% and repurchased $250 million of its common stock during the quarter.

“We delivered a strong third quarter with growth across brands, channels and geographies, while expanding margins year over year through disciplined execution of our brand strategies. The Crocs Brand delivered a record third quarter with revenues up 4%, led by double-digit international revenue growth and continued momentum across our product diversification strategy.”

Andrew Rees, Chief Executive Officer

“The strength of our business model and exceptional free-cash-flow generation provides us with significant flexibility to invest behind our brands while returning meaningful capital to shareholders. During the quarter, we returned $250 million to shareholders through share repurchases while continuing to strengthen our balance sheet through debt paydown.”

Andrew Rees, Chief Executive Officer
7:02 AM ET 8-K
Financial Results Bandwidth Inc. BAND

Bandwidth Financial Results

Bandwidth Inc. reported record third quarter 2026 revenue of $234 million, a 22% increase year-over-year, driven by increased platform usage and new enterprise customer wins. The company also amended its credit agreement to increase revolving credit commitments from $150 million to $200 million and extended the maturity date to October 2031.

Term
Q3 2026

“We delivered another strong quarter, with record results in all key financial metrics, highlighting the value that we are bringing to enterprises that are increasingly entrusting us to power SI-driven communication workflows.”

David Morken, Bandwidth’s Co-Founder, Chief Executive Officer, and Chairman

“Our third quarter results demonstrate our continued focus and execution, with record revenue, Adjusted EBITDA, and free cash flow. Our growth this quarter was driven by customers expanding their usage of our platform, and our sales team added four new $1 million-plus customer wins and expansions that will layer into our results over the next twelve months.”

Daryl Raiford, CFO of Bandwidth
7:02 AM ET 10-Q
Financial Results Altisource Portfolio Solutions S.A. ASPS

Altisource Portfolio Solutions Q3 2026 Results: Net Loss of $1.4M, Loss Narrows

Altisource Portfolio Solutions S.A. reported a net loss of $2.6 million for the nine months ended September 30, 2026, compared to a net income of $8.8 million in the prior year period. While total revenue increased to $150.2 million from $128.6 million, the company faced higher costs of revenue and a significant swing in income tax benefits which impacted the year-over-year bottom line.

Key figure
Net loss $1.4M
7:02 AM ET 8-K
Financial Results Insmed Inc INSM

Insmed Financial Results

Insmed reported third-quarter 2026 total revenues of $524.4 million, driven by strong commercial momentum for BRINSUPRI and ARIKAYCE. The company raised its full-year 2026 revenue guidance for both products following the successful launch of BRINSUPRI in Japan and continued growth in the U.S. market.

“The third quarter marked another period of meaningful progress, defined by commercial momentum, regulatory achievements, and advancement across our diversified pipeline. BRINSUPRI’s U.S. launch continues to exceed expectations and ARIKAYCE continues to grow while in its ninth year on the market. This performance supports our decision to raise the low end of our full-year 2026 revenue guidance for both products.”

Will Lewis, Chair and Chief Executive Officer of Insmed
7:01 AM ET 8-K
Financial Results Entegris Inc ENTG

Entegris Financial Results

Entegris reported record third-quarter 2026 revenue of $1,006 million, exceeding its guidance range due to strong demand in semiconductor unit and capex businesses. The company achieved significant margin expansion and strong earnings growth, while also delivering record cash flow used for debt repayment.

Term
Q3 2026

“Entegris is executing well against an attractive long-term opportunity, driven by increasing semiconductor complexity, rising materials intensity, and investment in leading-edge technologies. Our ability to deliver the performance, quality, and reliability our customers require is helping us expand plans of record and secure new design wins, driving strong revenue growth across our unit and capex businesses. That growth, combined with disciplined execution, drove another strong quarter, highlighted by record revenue, continued margin expansion and strong earnings growth, all of which exceeded our guidance range.”

Dave Reeder, Entegris’ President and Chief Executive Officer
7:01 AM ET 8-K
Financial Results TPG Inc. TPG

TPG Financial Results

TPG Inc. reported its third quarter 2026 financial results, highlighting $15 billion in fundraising during the quarter and nearly $42 billion year-to-date. The firm declared a quarterly dividend of $0.55 per share and reported record dry powder of $86 billion.

Term
3 years

“TPG delivered an exceptional third quarter, reflecting broad-based momentum across the firm and continued progress across each of our strategic objectives. Given the quality of our investment performance and the depth of our relationships, we expect to exceed our fundraising target of $50 billion this year, with $15 billion raised in the quarter and nearly $42 billion year-to-date. With a record $86 billion of dry powder and an increasingly attractive opportunity set ahead, we are well positioned to capitalize on this environment and create long-term value for our stakeholders.”

Jon Winkelried, Chief Executive Officer
7:01 AM ET 8-K
Financial Results Tradeweb Markets Inc. TW

Tradeweb Markets Financial Results

Tradeweb Markets reported Q3 2026 revenue of $584.5 million, up 14.9% year-over-year, driven by record average daily volumes of $3.2 trillion. The company also highlighted its recent agreement to acquire Trumid, the largest acquisition in its history, to accelerate its global credit strategy.

Term
Q3 2026

“Our third quarter 2026 revenue and volumes reflect the strength and breadth of our global, multi-asset platform, with average daily volume increasing 22.4% year-over-year. Against a backdrop of rising Treasury yields, shifting central bank policy and geopolitical uncertainty, we continued helping clients access liquidity and manage risk while investing in opportunities to drive our long-term growth.”

Billy Hult, CEO of Tradeweb

“In October, we announced our agreement to acquire Trumid, the largest acquisition in our history and a significant step forward in our credit strategy. We've always been builders of marketplaces, and this transaction reflects our belief in combining strategic acquisitions with organic innovation.”

Billy Hult, CEO of Tradeweb
7:01 AM ET 10-Q
Financial Results Pediatrix Medical Group, Inc. MD

Pediatrix Medical Group Q3 2026 Results: Net Income $47M, Down 34.5% YoY

Pediatrix Medical Group reported net revenue of $501.4 million for the quarter ended September 30, 2026, a slight increase from $492.9 million in the prior year. Net income for the quarter decreased to $47.0 million from $71.7 million, primarily due to a $20.9 million gain on divested businesses in 2025 that did not recur. The company significantly increased its share repurchase activity, spending $147.2 million during the first nine months of 2026.

Key figure
Net income $47M · -34.5% YoY
7:01 AM ET 10-Q
Financial Results Insmed Inc INSM

Insmed Q3 2026 Results: Net Loss of $100M, Loss Narrows

Insmed reported a significant increase in product revenues to $524.4 million for the third quarter of 2026, compared to $142.3 million in the prior year period. Despite the revenue growth, the company recorded a net loss of $100.3 million for the quarter, though this was a substantial improvement from the $370.0 million net loss in Q3 2025, primarily driven by higher sales and a decrease in the fair value of contingent consideration.

Key figure
Net loss $100M
7:01 AM ET 8-K
Financial Results First Mid Bancshares, Inc. FMBH

First Mid Bancshares Financial Results

First Mid Bancshares reported record quarterly net income of $33.3 million for Q3 2026, driven by strong asset quality and solid deposit growth. The company also announced a pending acquisition of Evergreen Bancshares and its subsidiary American Bank of Freedom to expand its presence in Missouri, Illinois, and Indiana.

Term
Q3 2026

“We delivered another strong period of financial results highlighted by a record high quarter of earnings. Asset quality was strong with lower classifieds and negligible net charge-offs during the quarter. Deposit growth was solid, while loan growth was pressured due to higher payoff activity from customer collateral sales.”

Matthew Smith, Chief Executive Officer

“I am pleased to announce our pending acquisition of Evergreen Bancshares and its subsidiary American Bank of Freedom. We are excited to welcome their employees and customers to the First Mid family. This acquisition will deepen and extend our presence in Missouri, Illinois, and Indiana while better positioning us to move past the $10 billion asset threshold.”

Matthew Smith, Chief Executive Officer
7:01 AM ET 8-K
Financial Results NovoCure Ltd NVCR

NovoCure Financial Results

Novocure reported record third-quarter net revenues of $193.4 million, a 16% year-over-year increase driven by 19% growth in active patients. The company significantly narrowed its net loss to $10.4 million and raised its full-year 2026 revenue and adjusted EBITDA guidance based on strong commercial performance.

Term
Q3 2026

“Novocure’s strong third quarter performance was driven by continued growth in our Optune Gio business and our growing portfolio of products launching in new markets, resulting in a record number of active patients on our therapies.”

Frank Leonard, CEO, Novocure

“We achieved record-high quarterly net revenue and are well-positioned to achieve the commercial, clinical and financial goals we set out in January. Based on the results from this quarter, we have raised our financial guidance for 2026 and will continue to build on the strong progress we have made on our path to profitability.”

Frank Leonard, CEO, Novocure
7:01 AM ET 8-K
Financial Results Norwegian Cruise Line Holdings Ltd. NCLH

Norwegian Cruise Line Holdings Financial Results

Norwegian Cruise Line Holdings reported Q3 2026 total revenue of $2.9 billion and GAAP net income of $491 million, exceeding its previous guidance. The company raised its full-year 2026 Adjusted EBITDA guidance to $2.55 billion and Adjusted EPS to $1.70, citing strong close-in demand and onboard spending.

Term
Q3 2026

“We delivered third quarter results that came in above guidance, all while continuing to strengthen our commercial capabilities, improve operating efficiency and enhance the guest experience. As we implement the next phase of our turnaround, we are focused on sharpening Norwegian Cruise Line’s brand positioning, improving marketing effectiveness and taking a more disciplined approach to revenue management as well as a prudent base-loading strategy.”

John W. Chidsey, Chairperson and Chief Executive Officer
7:01 AM ET 8-K
Financial Results Donnelley Financial Solutions, Inc. DFIN

Donnelley Financial Solutions Financial Results

Donnelley Financial Solutions (DFIN) reported third-quarter 2026 net sales of $185.0 million, a 5.5% increase year-over-year, driven by growth in software solutions and capital markets transactional revenue. The company achieved net earnings of $21.3 million, or $0.85 per diluted share, compared to a net loss in the prior-year period. Software solutions now account for 51.5% of total net sales, led by strong momentum in the ActiveDisclosure platform.

Term
Q3 2026

“We are pleased with our performance in the quarter, which featured 5.5% consolidated net sales growth, an increase in Adjusted EBITDA, and Adjusted EBITDA margin expansion. Software solutions net sales increased 5.0% versus the third quarter of 2025, driven by the continued momentum of ActiveDisclosure, a component of our compliance offerings, which grew approximately 24% as we continued to expand client adoption, increase the value of our offering, and migrate certain traditional services onto the platform.”

Daniel N. Leib, DFIN’s President and Chief Executive Officer

“During the third quarter, capital markets deal volume moderated from the levels we experienced during the first half of the year, especially in the number of priced IPOs, though overall market activity continued to improve compared to the third quarter of last year, resulting in higher capital markets transactional revenue.”

Daniel N. Leib, DFIN’s President and Chief Executive Officer
7:01 AM ET 8-K
Financial Results NCL Corp Ltd. NCLH

NCL Corp Financial Results

NCL Corporation Ltd. reported third quarter 2026 financial results with total revenue of $2.9 billion and GAAP net income of $491 million. The company raised its full-year 2026 guidance, now expecting Adjusted EBITDA of approximately $2.55 billion and Adjusted EPS of $1.70.

Term
Q3 2026

“We delivered third quarter results that came in above guidance, all while continuing to strengthen our commercial capabilities, improve operating efficiency and enhance the guest experience. As we implement the next phase of our turnaround, we are focused on sharpening Norwegian Cruise Line’s brand positioning, improving marketing effectiveness and taking a more disciplined approach to revenue management as well as a prudent base-loading strategy.”

John W. Chidsey, Chairperson and Chief Executive Officer
7:00 AM ET 10-Q
Financial Results NovoCure Ltd NVCR

NovoCure Q3 2026 Results: Net Loss of $10.4M, Loss Narrows

For the nine months ended September 30, 2026, NovoCure reported net revenues of $551.0 million, a 14.6% increase compared to the same period in 2025. Despite the revenue growth, the company recorded a net loss of $97.2 million for the first nine months of 2026, though this was an improvement from the $111.7 million net loss in the prior year period.

Key figure
Net loss $10.4M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.